ADXN CH0029850754

Report

Delayed Swiss Exchange - 07:03 2022-08-16 am EDT
0.2310	CHF		-3.75%

08/15	ADDEX THERAPEUTICS : and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for Substance Use Disorders - Form 6-K	PU
08/15	Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding	MT
08/15	Addex, Indivior to Include Chronic Cough Indication in Research Collaboration	MT

Most relevant news about ADDEX THERAPEUTICS LTD

08/15	ADDEX THERAPEUTICS : and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..	PU
08/15	Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding	MT
08/15	Addex, Indivior to Include Chronic Cough Indication in Research Collaboration	MT
08/15	Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..	GL
08/15	Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..	DJ
08/15	Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..	CI
08/12	Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..	GL
08/12	Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..	AQ
07/27	Addex Therapeutics Raises $4 Million In Americal Depositary Receipts Offering	MT
07/26	ADDEX THERAPEUTICS : Completes $4.2 Million Equity Financing - Form 6-K	PU
07/26	Addex Completes $4.2 Million Equity Financing	GL
07/26	Addex Completes $4.2 Million Equity Financing	DJ
07/26	Addex Therapeutics Ltd announced that it has received $2.9575 million in funding from A..	CI
07/22	Addex Therapeutics Signs $4.2 Million Equity Financing Deal With Armistice Master Fund	MT
07/22	ADDEX THERAPEUTICS : Raises $4.2 million in Equity Financing - Form 6-K	PU

All news about ADDEX THERAPEUTICS LTD

08/15	ADDEX THERAPEUTICS : and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..	PU
08/15	Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding	MT
08/15	Addex, Indivior to Include Chronic Cough Indication in Research Collaboration	MT
08/15	Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..	GL
08/15	Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..	DJ
08/15	Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..	CI
08/12	Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..	GL
08/12	Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..	AQ
07/27	Addex Therapeutics Raises $4 Million In Americal Depositary Receipts Offering	MT
07/26	ADDEX THERAPEUTICS : Completes $4.2 Million Equity Financing - Form 6-K	PU

News in other languages on ADDEX THERAPEUTICS LTD

08/15	Addex Therapeutics et Indivior PLC prolongent leur accord de collaboration et ajoutent ..
08/15	Addex et Indivior vont inclure l'indication de la toux chronique dans leur collaboratio..
08/15	Addex erweitert Zusammenarbeit mit Indivior und sichert sich zusätzliche Mittel
08/15	Addex étend sa collaboration avec Indivior
08/15	Addex et Indivior étendent leur collaboration en matière de recherche sur les modulateu..
07/27	Addex Therapeutics lève 4 millions de dollars dans le cadre d'une offre de certificats ..
07/26	Addex a finalisé une augmentation de capital
07/26	Addex schliesst Aktienkapitalerhöhung ab
07/22	Aktien Schweiz von schwachen Daten belastet
07/22	Addex Therapeutics signe un accord de financement par actions de 4,2 millions de dollar..

Analyst Recommendations on ADDEX THERAPEUTICS LTD

06/23	HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy	MT
05/31	HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Ratin..	MT
02/11	HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy R..	MT
2021	ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Pri..	MT

Press releases

08/15	ADDEX THERAPEUTICS : and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..	PU
08/15	Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..	GL
08/12	Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..	GL
08/12	Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..	AQ
07/26	ADDEX THERAPEUTICS : Completes $4.2 Million Equity Financing - Form 6-K	PU

Upcoming event on ADDEX THERAPEUTICS LTD

08/18/22

Upcoming sector events

10/26/22	IQVIA HOLDINGS INC. : Q3 2022 Earnings Release (Projected)
10/27/22	ALNYLAM PHARMACEUTICALS, INC. : Q3 2022 Earnings Release (Projected)
10/27/22	SEAGEN INC. : Q3 2022 Earnings Release (Projected)
11/03/22	MODERNA, INC. : Q3 2022 Earnings Release (Projected)

Sector

Healthcare
	Pharmaceuticals & Medical Research
		Biotechnology & Medical Research
			Biotechnology & Medical Research
				Other Biotechnology & Medical Research